BeyondSpring’s Plinabulin Continues to Build on Superior Product Profile in Breast Cancer Trial for Neutropenia Prevention

NEXT STORY
Auransa Presents New Preclinical Data on AU-409, a Novel, AI-Derived Drug Candidate for the Treatment of Hepatocellular Carcinoma
PREV STORY
First Data On Combination Of Enlivex’s Allocetra-OTS Immunotherapy and CAR-T Therapy Designed For Treating Solid Tumors Revealed At The Joint IIS-ISCR Special 2019 Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Data Published in Cancer Medicine Demonstrate Clinical Genomics’ Blood Test for Colorectal Cancer Recurrence is Two-Fold More Sensitive than CEA Test

BRIDGEWATER, N.J., Oct. 12, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing ...

author_avatar
NASDAQ Market News

Zai Lab Announces Early Completion of Enrollment for ZL-2306 PK Study

SHANGHAI, China, May 21, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based ...

author_avatar
NASDAQ Market News

GEn1E Lifesciences Adds to Development Pipeline with Exclusive Option to License University of Maryland, Baltimore’s MUC1-Ecto-Domain Anti-Bacterial Agent

Provides GEn1E the potential to enter clinic with a therapy for Pseudomonas infections in ...

author_avatar
NASDAQ Market News